Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to ...

Dollar Tree leadership is still working on a strategy for its Family Dollar brand. Shutterstock This story was originally ...

S&P 500 rises Friday despite stagflation fears. Safe-haven stocks outperform, while Nvidia, Dell, and HP Inc. slide on ...

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

Most analysts are staying on the sidelines. Of the 18 analysts covering WBA tracked by S&P Global Market Intelligence, four ...

Wall Street's main indexes were mixed in choppy trading on Friday as investors avoided large bets after data showed consumer ...

From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal Dispatch.

It is a sign of the strength of Godolphin's team that he is not the first string in this 1m4f contest, and William Buick has ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.